China Regenerative Medicine International (CRMI) (08158) said its executive Director Dai Yumin acquired 235,000 ordinary shares on the market yesterday.
After such purchase, Dai holds about 23.75% interests in CRMI.
12/02/2016 10:13
China Regenerative Medicine International (CRMI) (08158) said its executive Director Dai Yumin acquired 235,000 ordinary shares on the market yesterday.
After such purchase, Dai holds about 23.75% interests in CRMI.
Stocks
Futures
Warrants / CBBC
ETF